Ubiquitously expressed hematological and neurological expressed 1 downregulates Akt-mediated GSK3β signaling, and its knockdown results in deregulated G2/M transition in prostate cells

DNA and Cell Biology

Volumn 30, Issue 6, 2011, Pages 419-429

  Varisli, Lokman ^a,b   Gonen Korkmaz, Ceren ^b   Debelec Butuner, Bilge ^a,b   Erbaykent Tepedelen, Burcu ^a,b   Muhammed, Hamid Syed ^a,b   Bogurcu, Nuray ^a,b   Saatcioglu, Fahri ^c   Korkmaz, Kemal Sami ^a,b  

^a Faculty of Engineering   (Turkey)

^b EGE UNIVERSITY   (Turkey)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3BETA; MYC PROTEIN; PROTEIN; PROTEIN HN1; RECOMBINANT EPIDERMAL GROWTH FACTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL STRAIN LNCAP; CELL STRAIN MCF 7; CODON; CONTROLLED STUDY; DOWN REGULATION; EXON; FLOW CYTOMETRY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; MITOSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TETRAPLOIDY; TRANSLATION INITIATION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; BETA CATENIN; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; CHROMONES; CLONING, MOLECULAR; CYCLIN B1; CYCLIN D1; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; FLAVONOIDS; GENE KNOCKDOWN TECHNIQUES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MORPHOLINES; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PROSTATE; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TETRAPLOIDY; UP-REGULATION;

EID: 79958241545     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2010.1128     Document Type: Article

References (50)

1. Amanchy, R., Periaswamy, B., Mathivanan, S., Reddy, R., Tat-tikota, S.G., and Pandey, A. (2007). A curated compendium of phosphorylation motifs. Nat Biotechnol 25, 285-286.
2. Ashihara, K., Saito, T., Mizumoto, H., Nishimura, M., Tanaka, R., and Kudo, R. (2002). Mutation of beta-catenin gene in en-dometrial cancer but not in associated hyperplasia. Med Electron Microsc 35, 9-15. (Pubitemid 34601463)
3. Bhalla, K.N. (2003). Microtubule-targeted anticancer agents and apoptosis. Oncogene 22, 9075-9086. (Pubitemid 38121708)
4. Cartharius, K., Frech, K., Grote, K., Klocke, B., Haltmeier, M., Klingenhoff, A., et al. (2005). MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21, 2933-2942. (Pubitemid 40916416)
5. Conacci-Sorrell, M., Zhurinsky, J., and Ben-Ze'ev, A. (2002). The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 109, 987-991. (Pubitemid 34408571)
6. Dyrskjot, L., Kruhoffer, M., Thykjaer, T., Marcussen, N., Jensen, J.L., Moller, K., et al. (2004). Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res 64, 4040-4048. (Pubitemid 38697320)
7. El-Rayes, B.F., and LoRusso, P.M. (2004). Targeting the epidermal growth factor receptor. Br J Cancer 91, 418-424. (Pubitemid 39093557)
8. Frame, S., and Cohen, P. (2001). GSK3 takes centre stage more than 20 years after its discovery. Biochem J 359, 1-16. (Pubitemid 32939202)
9. Goto, T., Hisatomi, O., Kotoura, M., and Tokunaga, F. (2006). Induced expression of hematopoietic- and neurologic-expressed sequence 1 in retinal pigment epithelial cells during newt retina regeneration. Exp Eye Res 83, 972-980. (Pubitemid 44292692)
10. Hajra, K.M., and Fearon, E.R. (2002). Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 34, 255-268. (Pubitemid 34553304)
11. Hart, M.J., de los Santos, R., Albert, I.N., Rubinfeld, B., and Polakis, P. (1998). Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr Biol 8, 573-581. (Pubitemid 28222891)
12. Huang, G.M., Ng, W.L., Farkas, J., He, L., Liang, H.A., Gordon, D., et al. (1999). Prostate cancer expression profiling by cDNA sequencing analysis. Genomics 59, 178-186. (Pubitemid 29365348)
13. Hughes, K., Nikolakaki, E., Plyte, S.E., Totty, N.F., and Wood-gett, J.R. (1993). Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J 12, 803-808. (Pubitemid 23073729)
14. Iacobuzio-Donahue, C.A., Maitra, A., Olsen, M., Lowe, A.W., van Heek, N.T., Rosty, C., et al. (2003). Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol 162, 1151-1162. (Pubitemid 36350660)
15. Ihara, A., Koizumi, H., Hashizume, R., and Uchikoshi, T. (1996). Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinomas. Hepa-tology 23, 1441-1447. (Pubitemid 26181227)
16. Jorissen, R.N., Walker, F., Pouliot, N., Garrett, T.P., Ward, C.W., and Burgess, A.W. (2003). Epidermal growth factor receptor: mechanismsofactivation and signalling. Exp CellRes 284, 31-53. (Pubitemid 36331965)
17. Karpova, N., Bobinnec, Y., Fouix, S., Huitorel, P., and Debec, A. (2006). Jupiter, a new Drosophila protein associated with mi-crotubules. Cell Motil Cytoskeleton 63, 301-312.
18. Kishida, S., Yamamoto, H., Ikeda, S., Kishida, M., Sakamoto, I., Koyama, S., et al. (1998). Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin. J Biol Chem 273, 10823-10826. (Pubitemid 28204914)
19. Kobayashi, M., Honma, T., Matsuda, Y., Suzuki, Y., Narisawa, R., Ajioka, Y., et al. (2000). Nuclear translocation of beta-catenin in colorectal cancer. Br J Cancer 82, 1689-1693. (Pubitemid 30229580)
20. Korkmaz, C.G., Korkmaz, K.S., Manola, J., Xi, Z., Risberg, B., Danielsen, H., et al. (2004). Analysis of androgen regulated homeobox gene NKX3.1 during prostate carcinogenesis. J Urol 172, 1134-1139. (Pubitemid 39096487)
21. Korkmaz, K.S., Korkmaz, C.G., Ragnhildstveit, E., Pretlow, T.G., and Saatcioglu, F. (2000). An efficient procedure for cloning hormone-responsive genes from a specific tissue. DNA Cell Biol 19, 499-506. (Pubitemid 32186444)
22. Korkola, J.E., Houldsworth, J., Chadalavada, R.S., Olshen, A.B., Dobrzynski, D., Reuter, V.E., et al. (2006). Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res 66, 820-827. (Pubitemid 43165947)
23. Landi, M.T., Dracheva, T., Rotunno, M., Figueroa, J.D., Liu, H., Dasgupta, A., et al. (2008). Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS One 3, e1651.
24. Laughlin, K.M., Luo, D., Liu, C., Shaw, G., Warrington, K.H., Jr., Law, B.K., et al. (2009a). Hematopoietic- and neurologic-expressed sequence 1 (Hn1) depletion in B16.F10 melanoma cells promotes a differentiated phenotype that includes increased melanogenesis and cell cycle arrest. Differentiation 78, 35-44.
25. Laughlin, K.M., Luo, D., Liu, C., Shaw, G., Warrington, K.H., Jr., Qiu, J., et al. (2009b). Hematopoietic- and neurologic-expressed sequence 1 expression in the murine GL261 and high-grade human gliomas. Pathol Oncol Res 15, 437-444.
26. Lee, J., Kotliarova, S., Kotliarov, Y., Li, A., Su, Q., Donin, N.M., et al. (2006). Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9, 391-403. (Pubitemid 43668737)
27. Liu, J., Stevens, J., Rote, C.A., Yost, H.J., Hu, Y., Neufeld, K.L., et al. (2001). Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell 7, 927-936. (Pubitemid 32525740)
28. Lu, K.H., Patterson, A.P., Wang, L., Marquez, R.T., Atkinson, E.N., Baggerly, K.A., et al. (2004). Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res 10, 3291-3300. (Pubitemid 38685433)
29. Maruyama, K., Ochiai, A., Akimoto, S., Nakamura, S., Baba, S., Moriya, Y., et al. (2000). Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human co-lorectal cancer. Oncology 59, 302-309.
30. Nelson, W.J., and Nusse, R. (2004). Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303, 1483-1487. (Pubitemid 38314410)
31. Odajima, T., Sasaki, Y., Tanaka, N., Kato-Mori, Y., Asanuma, H., Ikeda, T., et al. (2005). Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features. Hum Pathol 36, 234-241. (Pubitemid 40404006)
32. Olsen, J.V., Blagoev, B., Gnad, F., Macek, B., Kumar, C., Mortensen, P., et al. (2006). Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127, 635-648. (Pubitemid 44647421)
33. Paul, S., and Dey, A. (2008). Wnt signaling and cancer development: therapeutic implication. Neoplasma 55, 165-176.
34. Rayasam, G.V., Tulasi, V.K., Sodhi, R., Davis, J.A., and Ray, A. (2009). Glycogen synthase kinase 3: more than a namesake. Br J Pharmacol 156, 885-898.
35. Rhodes, D.R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., et al. (2004). ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6, 1-6. (Pubitemid 38391943)
36. Richardson, A.L., Wang, Z.C., De Nicolo, A., Lu, X., Brown, M., Miron, A., et al. (2006). X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 9, 121-132. (Pubitemid 43202662)
37. Riker, A.I., Enkemann, S.A., Fodstad, O., Liu, S., Ren, S., Morris, C., et al. (2008). The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 1, 13.
38. Sanchez-Carbayo, M., Socci, N.D., Lozano, J., Saint, F., and Cordon-Cardo, C. (2006). Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oli-gonucleotide microarrays. J Clin Oncol 24, 778-789. (Pubitemid 46622045)
39. Stambolic, V., and Woodgett, J.R. (1994). Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem J 303 (Pt 3), 701-704. (Pubitemid 24325998)
40. Su, L.J., Chang, C.W., Wu, Y.C., Chen, K.C., Lin, C.J., Liang, S.C., et al. (2007). Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap resampling scheme. BMC Genomics 8, 140.
41. Tang, W., Lai, Y.H., Han, X.D., Wong, P.M., Peters, L.L., and Chui, D.H. (1997). Murine Hn1 on chromosome 11 is expressed in hemopoietic and brain tissues. Mamm Genome 8, 695-696. (Pubitemid 28060623)
42. Thompson, J.D., Higgins, D.G., and Gibson, T.J. (1994). CLUS-TAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22, 4673-4680. (Pubitemid 24354800)
43. Toledo, E.M., Colombres, M., and Inestrosa, N.C. (2008). Wnt signaling in neuroprotection and stem cell differentiation. Prog Neurobiol 86, 281-296.
44. Tomlins, S.A., Mehra, R., Rhodes, D.R., Cao, X., Wang, L., Dha-nasekaran, S.M., et al. (2007). Integrative molecular concept modeling of prostate cancer progression. Nat Genet 39, 41-51. (Pubitemid 46026500)
45. Turashvili, G., Bouchal, J., Baumforth, K., Wei, W., Dziechciar-kova, M., Ehrmann, J., et al. (2007). Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer 7, 55.
46. Wang, Q.M., Fiol, C.J., DePaoli-Roach, A.A., and Roach, P.J. (1994). Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine/threo-nine phosphorylation. J Biol Chem 269, 14566-14574.
47. Yu, L.R., Zhu, Z., Chan, K.C., Issaq, H.J., Dimitrov, D.S., and Veenstra, T.D. (2007). Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra. J Proteome Res 6, 4150-4162. (Pubitemid 350158493)
48. Zhou, G., Wang, J., Zhang, Y., Zhong, C., Ni, J., Wang, L., et al. (2004). Cloning, expression and subcellular localization of HN1 and HN1L genes, as well as characterization of their orthologs, defining an evolutionarily conserved gene family. Gene 331, 115-123. (Pubitemid 38501598)
49. Zougman, A., and Wisniewski, J.R. (2006). Beyond linker his-tones and high mobility group proteins: global profiling of perchloric acid soluble proteins. J Proteome Res 5, 925-934.
50. Zujovic, V., Luo, D., Baker, H.V., Lopez, M.C., Miller, K.R., Streit, W.J., et al. (2005). The facial motor nucleus transcrip-tional program in response to peripheral nerve injury identifies HN1 as a regeneration-associated gene. J Neurosci Res 82, 581-591. (Pubitemid 41740459)